HSP90 inhibition by RGRN-305 and 17-AAG decreased proinflammatory protein secretion. حسب Hakim Ben Abdallah (14578241)

Naringenin decreases mitochondrial function. حسب Lauren A. Eanes (20995499)

HSP90 inhibition by RGRN-305 decreased the gene expression of proinflammatory cytokines induced by SARS-CoV-2 S protein. حسب Hakim Ben Abdallah (14578241)

Naringenin decreases total cell viability. حسب Lauren A. Eanes (20995499)

Introgression decreases allelic shuffling. حسب Enrique J. Schwarzkopf (6579275)

Tetrandrine decreases Mtb antigen presentation. حسب Elham Karamooz (2584474)

Repetitive stress induces a decrease in sound-evoked activity. حسب Ghattas Bisharat (20706928)

"…<p>(a) Left: noise-evoked activity rates at different noise intensities for chronically tracked PPys cells in baseline and repeated stress conditions (<i>N</i> = 5 mice, <i>n</i> = 285 neurons, mean ± SE). …"

Lymphocytes decreased in mouse pneumonia model. حسب Qi Xu (134661)

Cardamonin decreased the expression of lipogenic proteins. حسب Peiguang Niu (17044532)

CaMKKβ is involved in ST2-104-regulated decrease in autophagy. حسب Yingshi Ji (9013004)

CaMKKβ contributes to the decrease in apoptosis conferred by ST2-104. حسب Yingshi Ji (9013004)

ANN architecture. حسب Abdelfattah Dani (22226715)

"…<div><p>With the increasing demand for wind energy in the electric power generation industry, optimizing robust and efficient control strategies is essential for a wind energy conversion system (WECS). In this regard, this study proposes a novel hybrid control strategy for wind power systems directly coupled to a permanent-magnet synchronous generator (PMSG). …"

Study Flow Diagram. حسب Elizabeth S. Munroe (21568166)

Antibody and antigen responses to Ensovibep vs placebo day 1–90. حسب Elizabeth S. Munroe (21568166)

Antibody and antigen responses to Lufotrelvir vs placebo day 1–90. حسب Elizabeth S. Munroe (21568166)

Antibody and antigen responses after treatment with nMAb vs placebo, day 1-90 (pooled nMAb treatments). حسب Elizabeth S. Munroe (21568166)

Antibody and antigen responses to nMAb vs placebo day 1–90 for Sotrovimab. حسب Elizabeth S. Munroe (21568166)

Antibody and antigen responses to nMAb vs placebo day 1–90 for Amubarvimab/ Romlusevimab. حسب Elizabeth S. Munroe (21568166)

Antibody and antigen responses to nMAb vs placebo day 1–90 for Tixagevimab/ Cilgavimab. حسب Elizabeth S. Munroe (21568166)

Antibody and antigen responses to nMAb vs placebo day 1–90 for Bamlanivimab. حسب Elizabeth S. Munroe (21568166)